Biosimilar Hormones Global Market Report 2024

Description

Biosimilar hormones refer to hormone products that mirror the chemical structure of the hormones naturally produced by the human body. In many cases, these hormones in bioidentical drugs closely resemble those utilized in traditional hormone therapy. They are employed to address imbalances or deficiencies in hormone levels within individuals.

The primary categories of biosimilar hormones encompass teriparatide biosimilars, follitropin alfa biosimilars, insulin biosimilars, somatropin biosimilars, among others. Teriparatide, for instance, is a recombinant form of parathyroid hormone (PTH). It functions similarly to a component of human PTH and, when administered regularly, stimulates osteoblasts more than osteoclasts, thereby enhancing bone mass. These hormones find diverse applications in research and biotechnology, diagnostics, biocatalysts, therapeutics, and various other fields. They are made available through multiple distribution channels, including hospital and retail pharmacies, online pharmacies or e-pharmacy platforms, as well as specialty clinics, catering to different healthcare needs and preferences.

The biosimilar hormones market research report is one of a series of new reports from The Business Research Company that provides biosimilar hormones market statistics, including biosimilar hormones industry global market size, regional shares, competitors with a biosimilar hormones market share, detailed biosimilar hormones market segments, market trends and opportunities, and any further data you may need to thrive in the biosimilar hormones industry. The biosimilar hormones market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biosimilar hormones market size has grown exponentially in recent years. It will grow from $3.9 billion in 2023 to $4.98 billion in 2024 at a compound annual growth rate (CAGR) of 27.5%. The growth observed in the historical period can be attributed to several factors. These include the escalating prevalence of chronic diseases requiring hormone treatments, a growing aging population necessitating hormone management, heightened awareness regarding the benefits of biosimilar hormones, and expanded accessibility to healthcare services facilitating their use among a wider demographic. These factors collectively contributed to the growth and adoption of biosimilar hormones during this period.

The biosimilar hormones market size is expected to see exponentially grown in the next few years. It will grow to $11.77 billion in 2028 at a compound annual growth rate (CAGR) of 24.0%. Anticipated growth in the forecast period is expected due to several key factors. These include the expansion of hormone targets for treatment, increasing acceptance of biosimilar hormones among patients, advancements in manufacturing techniques enhancing production efficiency, governmental support, a wealth of growing clinical trial data supporting their efficacy, and wider accessibility to healthcare services.

The biosimilar hormones market is seeing growth due to the prevalence of deficiencies in growth and metabolic hormones. Advancements in treatments for hormone-related conditions have led to increased demand for biosimilar hormones, fueled by the estimated global prevalence of growth hormone deficiency (GHD) in children ranging from 1 in 3500 to 1 in 10000, as reported by the British Medical Journal in January 2022. Additionally, approximately 6,000 adults in the USA are projected to be diagnosed with growth hormone deficiency, underlining the escalating need to address hormonal deficiencies, which drives the market growth for biosimilar hormones.

The expanding prevalence of diabetes is anticipated to be a significant driver of growth in the biosimilar hormones market. Diabetes, a persistent condition affecting energy conversion from food, presents a substantial market opportunity for biosimilar hormones, particularly insulin, as safe and effective alternatives for diabetes management. Biosimilar growth hormone also plays a role in managing diabetes by enhancing blood sugar control in adults with type 1 and type 2 diabetes. The International Diabetes Federation's July 2021 report projects a surge in the global diabetic population to 643 million by 2030 and 783 million by 2045, compared to approximately 537 million adults living with diabetes in 2021. This escalating prevalence of diabetes is set to propel the biosimilar hormones market's growth in the foreseeable future.

Key players in the biosimilar hormones market are actively implementing strategic initiatives, such as expanding into untapped regions through new product launches, aiming to increase accessibility and capture wider market segments. Notably, Alvotech Holdings S.A., in February 2022, announced a strategic partnership with Fuji Pharma Co. Ltd., intending to develop biosimilar drug candidates specifically targeted for the Japanese market. This alliance represents a focused effort to create and market biosimilar medicines in Japan, demonstrating a strategic move to enhance market presence and generate higher revenues.

Major companies operating in the biosimilar hormones sector are innovating with new product launches to augment their market profitability. Novo Nordisk's FDA approval in April 2023 for Sogroya (somapacitan-beco) injection marks a significant milestone. Sogroya, designed as a once-weekly growth hormone therapy for children and adults, gained a new indication for treating children aged 2.5 years and older with growth failure due to insufficient endogenous growth hormone secretion. Supported by findings from the phase 3 REAL4 trial, this approval validates Sogroya's efficacy in addressing growth hormone deficiency in pediatric patients, representing a strategic move to strengthen their market position and profitability.

Major companies operating in the biosimilar hormones market include Teva Pharmaceutical Industries Ltd., Gedeon Richter Plc., Intas Pharmaceuticals Ltd., Biocon Limited, Mylan, Sanofi, Sandoz (Novartis), LG Life Sciences, Ferring Pharmaceuticals, GC Pharma, Pfizer Inc., Dr. Reddy's Laboratories, Amgen Inc., Eli Lilly and Company, Celltrion Inc., Samsungbioepis Co.Ltd., Merck & Co., Biogen Inc., Boehringer Ingelheim, Coherus BioSciences Inc., Alvotech, BioXpress Therapeutics, Cipla Limited, Lupin Ltd., Stada Arzneimittel AG, Torrent Pharmaceuticals, Zydus Cadila, Accord Healthcare, Hetero Drugs, Wockhardt

North America was the largest region in the biosimilar hormones market in 2023. The regions covered in the biosimilar hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the biosimilar hormones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The biosimilar hormones market consists of sales of estrace, estradil, and estring. Values in this market are 'factory gate values,' that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biosimilar Hormones Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biosimilar hormones market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biosimilar hormones? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biosimilar hormones market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Teriparatide Biosimilars; Follitropin Alfa Biosimilars; Insulin Biosimilars; Somatropin Biosimilars; Other Types
2) By Application: Research & Biotechnology; Diagnostics; Biocatalysts; Therapeutics; Other Applications
3) By Distribution Channel: Hospital And Retail Pharmacy; Online Pharmacy/pharmacy; Specialty Clinics
Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Gedeon Richter Plc.; Intas Pharmaceuticals Ltd.; Biocon Limited; Mylan
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13195

1. Executive Summary

2. Biosimilar Hormones Market Characteristics

3. Biosimilar Hormones Market Trends And Strategies

4. Biosimilar Hormones Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Biosimilar Hormones Market Size and Growth

5.1. Global Biosimilar Hormones Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Biosimilar Hormones Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Biosimilar Hormones Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biosimilar Hormones Market Segmentation

6.1. Global Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Teriparatide Biosimilars
Follitropin Alfa Biosimilars
Insulin Biosimilars
Somatropin Biosimilars
Other Types
6.2. Global Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Research & Biotechnology
Diagnostics
Biocatalysts
Therapeutics
Other Applications
6.3. Global Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital And Retail Pharmacy
Online Pharmacy/pharmacy
Specialty Clinics

7. Biosimilar Hormones Market Regional And Country Analysis

7.1. Global Biosimilar Hormones Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Biosimilar Hormones Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biosimilar Hormones Market

8.1. Asia-Pacific Biosimilar Hormones Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biosimilar Hormones Market

9.1. China Biosimilar Hormones Market Overview
9.2. China Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biosimilar Hormones Market

10.1. India Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biosimilar Hormones Market

11.1. Japan Biosimilar Hormones Market Overview
11.2. Japan Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biosimilar Hormones Market

12.1. Australia Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biosimilar Hormones Market

13.1. Indonesia Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biosimilar Hormones Market

14.1. South Korea Biosimilar Hormones Market Overview
14.2. South Korea Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biosimilar Hormones Market

15.1. Western Europe Biosimilar Hormones Market Overview
15.2. Western Europe Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biosimilar Hormones Market

16.1. UK Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biosimilar Hormones Market

17.1. Germany Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biosimilar Hormones Market

18.1. France Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biosimilar Hormones Market

19.1. Italy Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biosimilar Hormones Market

20.1. Spain Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biosimilar Hormones Market

21.1. Eastern Europe Biosimilar Hormones Market Overview
21.2. Eastern Europe Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biosimilar Hormones Market

22.1. Russia Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biosimilar Hormones Market

23.1. North America Biosimilar Hormones Market Overview
23.2. North America Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biosimilar Hormones Market

24.1. USA Biosimilar Hormones Market Overview
24.2. USA Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biosimilar Hormones Market

25.1. Canada Biosimilar Hormones Market Overview
25.2. Canada Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biosimilar Hormones Market

26.1. South America Biosimilar Hormones Market Overview
26.2. South America Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biosimilar Hormones Market

27.1. Brazil Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biosimilar Hormones Market

28.1. Middle East Biosimilar Hormones Market Overview
28.2. Middle East Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biosimilar Hormones Market

29.1. Africa Biosimilar Hormones Market Overview
29.2. Africa Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Biosimilar Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biosimilar Hormones Market Competitive Landscape And Company Profiles

30.1. Biosimilar Hormones Market Competitive Landscape
30.2. Biosimilar Hormones Market Company Profiles
- 30.2.1. Teva Pharmaceutical Industries Ltd.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Gedeon Richter Plc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Intas Pharmaceuticals Ltd.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Biocon Limited
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Mylan
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Biosimilar Hormones Market Competitive Benchmarking

32. Global Biosimilar Hormones Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Biosimilar Hormones Market

34. Biosimilar Hormones Market Future Outlook and Potential Analysis

34.1 Biosimilar Hormones Market In 2028 - Countries Offering Most New Opportunities
34.2 Biosimilar Hormones Market In 2028 - Segments Offering Most New Opportunities
34.3 Biosimilar Hormones Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer